VENMAX DRUGS AND PHARMACEUTICA Share Price

VENMAX DRUGS AND PHARMACEUTICA Share Price

BSE: 531015
|
Pharmaceuticals
|
S Cap
₹ 0.00
+0.00 (0.00%)
1D
--
--
--
1D LOW
1D HIGH

VENMAX DRUGS AND PHARMACEUTICA Returns Calculator

Circuit
L
H
--
--
52-week
L
H
--
--

About VENMAX DRUGS AND PHARMACEUTICA

VENMAX DRUGS AND PHARMACEUTICA Share Price
ISIN
INE154G01022
Sector Market Cap
₹ 21.70 Cr

Venmax Drugs and Pharmaceuticals Limited is an India-based company. The Company is engaged in the business of pharmaceutical products, drug intermediaries and active pharmaceutical ingredients (API’s). It is developing oncology products through research and development (R&D).

VENMAX DRUGS AND PHARMACEUTICA Financial Highlights

  • Revenue: VENMAX DRUGS AND PHARMACEUTICA reported revenue of ₹8.18 crore in FY26 vs ₹1.86 crore in FY25. It showed an increase of 339.78% on a yearly basis.
  • Operating Profit: VENMAX DRUGS AND PHARMACEUTICA reported an operating profit of ₹0.28 crore in FY26 vs ₹0.01 crore in FY25. It showed an increase of 2,900.00% on a year-on-year basis.
  • Net Profit: VENMAX DRUGS AND PHARMACEUTICA reported a net profit of ₹0.25 crore in FY26 vs ₹0.01 crore in FY25. It showed an increase of 2,600.00% on a yearly basis.

VENMAX DRUGS AND PHARMACEUTICA Quarterly Result Highlights

  • VENMAX DRUGS AND PHARMACEUTICA reported revenue of ₹2.48 crore in Jun 2026, compared with ₹4.03 crore in Mar 2026, representing a decrease of 38.46% on a quarter-on-quarter (QoQ) basis.
  • VENMAX DRUGS AND PHARMACEUTICA reported an operating profit of ₹0.12 crore in Jun 2026, compared with ₹0.10 crore in Mar 2026, representing an increase of 20.00% on a quarter-on-quarter (QoQ) basis.
  • VENMAX DRUGS AND PHARMACEUTICA reported a profit of ₹0.12 crore in Jun 2026, compared with ₹0.11 crore in Mar 2026, reflecting an increase of 9.09% on a QoQ basis.
  • The earnings per share (EPS) of VENMAX DRUGS AND PHARMACEUTICA stood at ₹0.21 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
10.46%
FII
0.00%
Other DII
0.00%
Retail and other
89.54%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
20.26
P/E
73.63
P/B
0.97
ROE
1.87%
D/E
0.01
ROCE
2.03%
Div. Yield
0.00%
EPS(TTM)
0.21
Turnover
0.55
EV/EBITDA
65.90
Net Margin
3.12%
Op. Margin
3.49%
ROA
1.66%
Quick Ratio
7.46
Curr. Ratio
10.45
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Venmax Drugs has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Venmax Drugs appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,48,196.0036.515.2913.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,50,390.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,967.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,860.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,888.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,00,329.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma98,803.9026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

VENMAX DRUGS AND PHARMACEUTICA Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹8.02₹0.81₹0.00₹0.00
Other Income₹0.16₹1.05₹0.20₹0.42
Total Revenue₹8.19₹1.86₹0.20₹0.42
Total Expenses₹7.91₹1.87₹0.11₹0.19
Profit Before Tax₹0.28-₹0.01₹0.09₹0.23
Tax₹0.03₹0.00₹0.02₹0.00
Profit After Tax₹0.25-₹0.01₹0.06₹0.23
EPS - Basic₹0.21-₹0.02₹0.12₹0.43
EPS - Diluted₹0.21-₹0.02₹0.12₹0.43

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.28-₹0.01₹0.09₹0.23
Income before WC changes₹0.28₹0.01₹0.09₹0.23
Change in Assets-₹12.29-₹2.63₹0.13-₹0.09
Change in Liabilities₹1.05₹0.33-₹0.19-₹0.14
Change in WC-₹11.25-₹2.30-₹0.07-₹0.24
Cash flow from Operations-₹11.00-₹2.29₹0.00₹0.00
Cash flow from Investing₹0.00₹0.00₹0.00₹0.00
Cash flow from Financing₹9.74₹4.77₹0.00₹0.00
Total Cash Flow-₹1.26₹2.48₹0.00₹0.00
Cash (Start of the year)₹2.48₹0.00₹0.00₹0.00
Cash (End of the year)₹1.22₹2.48₹0.00₹0.00

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹0.04₹0.04₹0.07₹0.07
Current Assets₹16.16₹5.13₹0.02₹0.14
Total Assets₹16.20₹5.17₹0.08₹0.21
Current Liabilities₹2.03₹0.71₹0.73₹0.92
Net Current Asset₹14.13₹4.42-₹0.71-₹0.78
Non-Current Liabilities₹0.05₹0.05₹0.00₹0.00
Equity Capital₹14.12₹4.41-₹0.65-₹0.71
Total Equity & Liabilities₹16.20₹5.17₹0.08₹0.21
* All values are in INR Crore
Qty
Bid
Ask
Qty
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
42.39
Neutral
ATR (14)
1.98
Neutral
STOCH(9,6)
33.86
Neutral
STOCH RSI (14)
56.86
Neutral
ADX(9)
17.41
Bullish
UO(9)
35
Neutral
ROC(12)
-0.92
Bearish
WillR(14)
-66.14
Neutral
Period
Simple value
Exponential vaue
5D
14.35
14.43
10D
14.52
14.57
20D
14.8
14.95
50D
16.11
16.28
100D
18.81
18.3
Volume trend — traded volume by day
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
16 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
VENMAX DRUGS AND PHARMACEUTICA Share Price
VENMAX DRUGS AND PHARMACEUTICA
Pharmaceuticals
Add Stock
Add Another

VENMAX DRUGS AND PHARMACEUTICA Share Price FAQs

VENMAX DRUGS AND PHARMACEUTICA share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837